No definition available.
Adenocarcinoma and Papillary adenocarcinoma of kidney
C3_KIDNEY_PAPILLARYADENO
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
454 |
4. Check minimum number of eventsNone |
454 |
5. Include endpointsNone |
454 |
6. Filter based on genotype QC (FinnGen only) |
408 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Adenocarcinoma and Papillary adenocarcinoma of kidney
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of kidney, except renal pelvis
- Malignant neoplasm of urinary organs
- Malignant neoplasm of kidney, except renal pelvis, including Hilmo
- Malignant neoplasm of urinary organs, including Hilmo
- Solid cancers
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 408 | 95 | 313 |
| Unadjusted period prevalence (%) | 0.12 | 0.03 | 0.14 |
| Median age at first event (years) | 67.61 | 67.79 | 67.55 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 428
- Matched controls
- 4280
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
895.9
307.7
364
27
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
307.7
412
*
8260/3-C64.9
ICD-O-3
Papillary adenocarcinoma, NOS, of kidney, NOS
+∞
307.7
428
*
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
108.0
216.1
112
14
JN4AD
NOMESCO Finland
Body CT examination
14.4
140.9
154
161
B01AB10
ATC
tinzaparin; parenteral
13.6
140.1
162
184
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
18.6
129.5
114
82
WX302
NOMESCO Finland
Thoracal epidural anesthesy
26.1
120.5
88
42
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
9.6
112.2
177
294
KAD00
NOMESCO Finland
Partial nephrectomy
670.6
108.9
103
*
JN4BD
NOMESCO Finland
Extensive body CT
13.0
101.2
110
111
KA1AE
NOMESCO Finland
Kidney ultrasound examination
21.2
100.6
80
46
KAD01
NOMESCO Finland
Percutaneous endoscopic partial nephrectomy
586.9
97.6
93
*
JN4CD
NOMESCO Finland
Very extensive body CT
28.9
87.1
60
24
KAC10
NOMESCO Finland
Total nephrectomy with capsule
+∞
83.1
77
*
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
477.7
81.9
79
*
TPH07
NOMESCO Finland
Cathetrisation of artery
7.3
78.6
148
288
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
+∞
74.2
69
*
130
Kela drug reimbursment
Malignant tumour
+∞
74.2
69
*
WX408
NOMESCO Finland
General anesthesy, balanced
5.2
62.7
201
620
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
12.6
61.4
64
59
JN3AD
NOMESCO Finland
Abdominal CT examination
6.1
60.3
131
287
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
15.2
59.9
55
41
WX402
NOMESCO Finland
General anaesthesia
5.0
56.2
173
510
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
15.6
55.4
50
36
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
6.6
51.6
97
183
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
13.4
49.7
49
41
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
46.7
44
*
ZXE20
NOMESCO Finland
More than three and less than five hours
5.1
46.0
122
313
B03XA02
ATC
darbepoetin alfa; parenteral
18.3
45.0
37
22
A11CC03
ATC
alfacalcidol; systemic
12.8
42.7
43
37
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
41.3
39
*
TK800
NOMESCO Finland
Hemodialysis
11.5
39.0
42
40
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
16.0
38.6
34
23
R4110
NOMESCO Finland
Physiotherapy
3.7
37.8
190
763
U14
ICPC
Kidney symptom/complaint
12.2
34.9
36
32
N02AX02
ATC
tramadol; systemic, rectal
3.4
33.9
267
1392
A12AA04
ATC
calcium carbonate; oral
13.8
33.5
32
25
B01AB05
ATC
enoxaparin; parenteral
3.4
32.5
189
817
L04AA06
ATC
mycophenolic acid; systemic
12.8
30.2
30
25
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.3
30.0
291
1671
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
111.1
29.1
31
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.9
28.7
71
168
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.7
27.5
72
178
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
27.4
26
*
A03FA01
ATC
metoclopramide; systemic, rectal
4.2
27.4
85
240
U75
ICPC
Malignant neoplasm of kidney
+∞
26.3
25
*
N18.8
ICD-10 Finland
Other chronic renal failure
8.3
26.3
36
47
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.3
26.1
57
121
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
25.3
24
*
KA3LT
NOMESCO Finland
Njurlesion coagulation
264.8
24.9
25
*
N28.1
ICD-10 Finland
Cyst of kidney
10.0
24.7
29
31
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.3
24.6
72
194
UKC02
NOMESCO Finland
Cystoscopy
3.3
24.4
117
439
ZXE10
NOMESCO Finland
More than one and less than three hours
2.8
24.4
194
967
WZC30
NOMESCO Finland
Teaching
3.5
24.3
100
341
WF002
NOMESCO Finland
Radical radiotherapy
92.1
23.9
26
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
6.6
23.7
40
66
XX3DW
NOMESCO Finland
Time consuming IT work
5.7
23.7
47
91
Z94.0
ICD-10 Finland
Kidney transplant status
30.2
23.5
31
11
ZXC96
NOMESCO Finland
Robot assisted procedure
55.2
22.3
26
5
197
Kela drug reimbursment
Sunitinib
+∞
22.1
21
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
22.1
21
*
Z51.5
ICD-10 Finland
Palliative care
5.4
21.9
46
94
WF049
NOMESCO Finland
Radiotherapy of metastasis
231.3
21.8
22
*
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
28.1
21.6
29
11
205
Kela drug reimbursment
Chronic hypertension
2.7
21.3
184
941
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
21.0
20
*
H02AB02
ATC
dexamethasone; systemic
17.2
20.4
32
20
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
6.0
20.3
37
66
116
Kela drug reimbursment
Prostate cancer
+∞
19.9
19
*
KAC00
NOMESCO Finland
Nephrectomy
+∞
19.9
19
*
V03AE01
ATC
polystyrene sulfonate; oral
18.9
19.9
30
17
127
Kela drug reimbursment
Transplant complication
18.9
19.9
30
17
TPH04
NOMESCO Finland
Cathetrisation of vein
2.8
19.5
135
614
ZXD10
NOMESCO Finland
Scheduled procedure
2.5
19.4
194
1054
N02AA05
ATC
oxycodone; systemic
3.0
19.0
99
385
R31
ICD-10 Finland
Unspecified haematuria
3.2
18.4
84
302
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.9
18.4
43
96
WW500
NOMESCO Finland
Blood transfusion
8.0
18.0
25
33
D30.0
ICD-10 Finland
Benign neoplasm: Kidney
28.1
18.0
24
9
Z49.1
ICD-10 Finland
Extracorporeal dialysis
13.4
17.4
30
24
C08CA01
ATC
amlodipine; oral
2.4
17.3
234
1437
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.9
16.9
96
390
L01XE04
ATC
[U] sunitinib
+∞
16.8
16
*
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
4.4
16.5
43
105
GD1AD
NOMESCO Finland
Thorax CT examination
4.0
16.4
49
133
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
31.4
16.3
21
7
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
49.5
16.1
19
*
L04AD02
ATC
tacrolimus; systemic
22.0
16.1
23
11
WZC00
NOMESCO Finland
Treatment plan or consultation
2.4
15.9
151
788
M04AA01
ATC
allopurinol; systemic
2.8
15.7
97
411
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
21.0
15.3
22
11
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
46.8
15.2
18
*
I10
ICD-10 Finland
Essential (primary) hypertension
2.6
15.0
334
2482
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
17.3
14.9
23
14
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
58.8
14.9
17
*
137
Kela drug reimbursment
Uraemia requiring dialysis
19.3
14.8
22
12
KA3CT
NOMESCO Finland
Biopsy of kidney under CT guidance
+∞
14.7
14
*
1502
Kela drug reimbursment
Cabozantinib
+∞
14.7
14
*
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
44.1
14.2
17
*
J01MA02
ATC
ciprofloxacin; systemic
2.2
14.2
198
1202
L02AE02
ATC
leuprorelin; implant, parenteral
55.2
13.9
16
*
S18
ICPC
Laceration/cut
2.2
13.7
241
1594
N18.0
ICD-10 Finland
End-stage renal disease
15.4
13.7
22
15
C08CA02
ATC
felodipine; oral
2.9
13.7
72
279
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
13.6
13
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
13.6
13
*
KAC01
NOMESCO Finland
Percutaneous endoscopic nephrectomy
+∞
13.6
13
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
13.6
13
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
144.4
13.5
14
*
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
26.7
13.5
18
7
SPAT1153
SPAT
Removal of sutures
2.2
13.4
162
924
C02AC05
ATC
moxonidine; oral
3.8
13.3
42
118
N02BE01
ATC
paracetamol; systemic, rectal
4.2
13.3
402
3361
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
17.4
13.1
20
12
ZXA05
NOMESCO Finland
Left side
2.3
13.0
132
698
H05BX01
ATC
cinacalcet; oral
19.8
13.0
19
10
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.2
13.0
143
783
J01MA12
ATC
levofloxacin; systemic
2.5
13.0
102
483
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
14.7
12.9
21
15
Z49.0
ICD-10 Finland
Preparatory care for dialysis
14.7
12.9
21
15
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
72.1
12.7
14
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
12.6
12
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
12.6
12
*
3012
Kela drug reimbursment
Cabozantinib
+∞
12.6
12
*
196
Kela drug reimbursment
Paricalcitol and cinacalcet
20.8
12.6
18
9
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.3
12.1
108
540
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
13.9
12.1
20
15
L04AA01
ATC
[U] ciclosporin
15.2
11.9
19
13
JN3AE, ,
SPAT
4.6
11.9
29
67
WX110
NOMESCO Finland
Infiltration anesthesia
2.2
11.8
309
2322
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.4
11.7
95
455
V03AE02
ATC
sevelamer; oral
23.7
11.6
16
7
ZXE00
NOMESCO Finland
One hour or less
2.1
11.6
171
1040
R4190
NOMESCO Finland
Nutritional therapy
5.9
11.6
21
37
XKD00
NOMESCO Finland
Uroflowmetry
2.3
11.6
102
506
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
11.5
11
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
11.5
11
*
L01EX07
ATC
cabozantinib; oral
+∞
11.5
11
*
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
123.2
11.5
12
*
Z3226
NOMESCO Finland
Physiotherapist
2.4
11.3
94
454
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
11.2
109
562
TPX10
NOMESCO Finland
Implantation of vascular injection port
9.6
11.1
22
24
Z2221
NOMESCO Finland
Medical doctor
2.2
11.1
123
670
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
14.4
11.1
18
13
R23.8
ICD-10 Finland
Other and unspecified skin changes
2.3
10.9
95
467
L04AD01
ATC
ciclosporin; systemic
12.4
10.9
19
16
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
10.9
148
870
321
Kela drug reimbursment
Paricalcitol and cinacalcet
18.4
10.8
16
9
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.8
10.7
33
91
UJF32
NOMESCO Finland
Coloscopy
2.1
10.6
129
726
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.7
10.5
34
97
KH1AD
NOMESCO Finland
CT of urinary organs
3.9
10.5
31
83
A79
ICPC
Malignancy NOS
+∞
10.5
10
*
322
Kela drug reimbursment
Sunitinib
+∞
10.5
10
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
10.5
10
*
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
24.1
10.3
14
6
C03CA01
ATC
furosemide; systemic
2.0
10.3
161
992
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
13.6
10.2
17
13
B05DA
ATC
Isotonic solutions
15.1
10.1
16
11
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
15.1
10.1
16
11
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
41.1
10.0
12
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.9
9.9
30
82
XX9XW, ,
NOMESCO Finland
56.3
9.7
11
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.0
9.7
28
74
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
7.4
9.6
22
31
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.4
9.5
72
332
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
18.0
9.5
14
8
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
102.2
9.5
10
*
Y77
ICPC
Malignant neoplasm prostate
102.2
9.5
10
*
WX306
NOMESCO Finland
Lumbar epidural anesthesy
4.7
9.4
22
49
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
9.4
9
*
159
Kela drug reimbursment
Pazopanib
+∞
9.4
9
*
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
22.3
9.4
13
6
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.4
9.4
34
105
N19
ICD-10 Finland
Unspecified kidney failure
3.6
9.4
31
90
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.6
9.3
56
231
G04CA02
ATC
tamsulosin; oral
1.9
9.2
176
1151
ZX120
NOMESCO Finland
Intravenous
3.2
9.0
37
124
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
3.4
9.0
33
103
N18.4
ICD-10 Finland
Chronic kidney disease, stage 4
8.2
8.9
19
24
Z49.2
ICD-10 Finland
Other dialysis
12.9
8.9
15
12
B01AB04
ATC
dalteparin; parenteral
3.9
8.9
26
69
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
5.1
8.9
19
39
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
3.8
8.9
27
74
R93.4
ICD-10 Finland
Abnormal findings on diagnostic imaging of urinary organs
11.0
8.9
16
15
C09AA02
ATC
enalapril; systemic
2.0
8.8
113
644
Z3231
NOMESCO Finland
Registered nurse
2.0
8.8
122
715
A02BC02
ATC
pantoprazole; systemic
1.9
8.7
299
2338
ZXA00
NOMESCO Finland
Right side
2.0
8.6
130
782
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.4
8.5
31
96
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
28.1
8.5
11
*
N11.9
ICD-10 Finland
Chronic tubulo-interstitial nephritis, unspecified
91.8
8.4
9
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.9
8.4
40
146
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
3.4
8.4
30
92
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
3.6
8.4
28
82
158
Kela drug reimbursment
Everolimus
+∞
8.4
8
*
168
Kela drug reimbursment
Axitinib
+∞
8.4
8
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
8.4
8
*
C64.80
ICD-10 Finland
Wilms tumour
+∞
8.4
8
*
H02AB06
ATC
prednisolone; systemic
1.8
8.3
205
1439
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
8.3
147
931
B05DB
ATC
Hypertonic solutions
14.8
8.2
13
9
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.4
8.2
61
278
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
22.5
8.1
11
5
B03XA01
ATC
erythropoietin; parenteral
22.5
8.1
11
5
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.4
8.0
59
269
TK810
NOMESCO Finland
Hemofiltration
9.7
7.8
15
16
D64.9
ICD-10 Finland
Anaemia, unspecified
2.3
7.8
62
291
Z31.5
ICD-10 Finland
Genetic counselling
6.6
7.8
19
30
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.5
7.8
27
81
C07AB02
ATC
metoprolol; systemic
2.0
7.8
107
622
C09BA02
ATC
enalapril and diuretics; systemic
2.5
7.7
49
208
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
12.1
7.6
13
11
V03AE03
ATC
lanthanum carbonate; oral
25.5
7.6
10
*
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
2.2
7.5
65
316
H02AB04
ATC
methylprednisolone; systemic
2.2
7.4
72
367
KB1CG
NOMESCO Finland
Extensive MRI examination of urinary tract with high intensity magnet
81.5
7.4
8
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
81.5
7.4
8
*
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
81.5
7.4
8
*
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
13.7
7.4
12
9
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.4
7.4
27
84
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
8.6
7.4
15
18
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
9.6
7.3
14
15
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
7.3
7
*
L01EX01
ATC
sunitinib; oral
+∞
7.3
7
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
7.3
7
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
7.3
7
*
L01XE11
ATC
[U] pazopanib
+∞
7.3
7
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
7.3
7
*
L01BC06
ATC
capecitabine; oral
+∞
7.3
7
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
7.3
7
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
7.3
7
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
7.3
7
*
C08CA13
ATC
lercanidipine; oral
2.0
7.2
83
451
J01DB01
ATC
cefalexin; oral
2.0
7.2
345
2900
NK6AN
NOMESCO Finland
Total body bone isotope imaging
30.6
7.2
9
*
R10.0
ICD-10 Finland
Acute abdomen
4.2
7.2
19
47
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.7
7.1
38
148
N03AX16
ATC
[U] pregabalin
1.9
7.0
104
617
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
14.1
6.9
11
8
R50.9
ICD-10 Finland
Fever, unspecified
2.2
6.9
65
328
PG5AC
NOMESCO Finland
Contrast examination of injection gate to artery or vein
40.7
6.8
8
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
22.9
6.7
9
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
8.0
6.7
14
18
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
12.5
6.6
11
9
TK820
NOMESCO Finland
Peritoneal dialysis
12.5
6.6
11
9
WX704
NOMESCO Finland
Intubation
2.6
6.6
40
166
M10.9
ICD-10 Finland
Gout, unspecified
2.3
6.6
52
244
KB1DG
NOMESCO Finland
Very extensive MRI of urinary tract
70.9
6.4
7
*
L03AA02
ATC
filgrastim; parenteral
70.9
6.4
7
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
70.9
6.4
7
*
KBV10
NOMESCO Finland
Removal of stent from ureter
14.6
6.4
10
7
UJF30
NOMESCO Finland
Ileoscopy through colon
2.3
6.4
50
233
JAH00
NOMESCO Finland
Laparotomy
5.3
6.4
18
35
N20.1
ICD-10 Finland
Calculus of ureter
3.1
6.4
27
92
XX2RW, ,
NOMESCO Finland
11.3
6.3
11
10
Z2446
NOMESCO Finland
Social worker
2.7
6.3
33
127
M05BX04
ATC
denosumab; parenteral
3.0
6.3
27
93
L01XE26
ATC
[U] cabozantinib
+∞
6.3
6
*
115
Kela drug reimbursment
Breast cancer
+∞
6.3
6
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
6.3
6
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
6.3
6
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
6.3
6
*
L01XE17
ATC
[U] axitinib
+∞
6.3
6
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
+∞
6.3
6
*
361
Kela drug reimbursment
Axitinib
+∞
6.3
6
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
6.3
6
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
6.3
6
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
6.3
6
*
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
+∞
6.3
6
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
6.3
125
811
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.4
6.1
22
68
ZXD05
NOMESCO Finland
Urgent procedure
1.7
6.1
126
825
WX290
NOMESCO Finland
Other blockage of nerve
1.7
6.1
177
1271
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
6.2
6.0
15
25
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
6.0
79
449
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
331
1580
5.83
58.19
4.0
2.6
—
—
estimate
—
0
0
325
1585
5.37
53.97
10.0
4.3
34.93
35.73
g/l
1.70
307
1473
260
1077
4.60
53.53
6.4
3.0
0.19
0.39
e6/l
2.59
216
775
142
373
5.20
52.64
14.2
7.0
12.06
10.70
mmol/l
1.44
136
355
223
833
4.50
52.62
3.3
2.3
—
—
—
0
0
167
520
4.63
49.75
16.6
5.8
1.10
1.02
mmol/l
2.26
159
479
116
269
5.54
49.44
9.1
10.1
23.03
24.38
mmol/l
5.53
116
263
116
281
5.29
46.84
10.2
4.6
165.46
103.75
ng/l
3.93
106
241
272
1251
4.22
46.40
6.9
3.1
20.28
98.36
e6/l
0.84
231
938
320
1678
4.59
44.67
17.1
6.4
1.20
1.20
mmol/l
0.26
303
1542
176
616
4.15
43.97
10.2
6.9
104.54
104.37
mmol/l
0.20
176
616
177
626
4.12
43.50
5.3
3.0
0.72
1.35
e6/l
1.00
93
307
211
857
3.88
42.16
4.8
2.4
2.79
3.56
e6/l
0.89
198
771
182
685
3.88
40.39
5.1
2.8
0.53
0.98
e6/l
2.04
100
366
156
531
4.05
39.99
9.4
8.5
-1.13
1.07
mmol/l
11.02
140
429
321
1883
3.82
33.54
19.0
6.8
1.21
1.20
mmol/l
0.31
285
1640
233
1142
3.28
32.37
5.1
2.1
2.37
2.35
mmol/l
1.53
209
984
392
2765
5.97
28.74
14.7
6.0
81.19
76.72
u/l
1.58
385
2580
74
182
4.71
28.53
3.8
1.5
3.10
2.75
ug/l
0.31
63
133
312
1910
3.34
28.00
17.8
17.4
1.21
1.33
inr
3.32
257
1597
313
1947
3.26
26.76
11.8
6.3
4.54
4.35
e9/l
0.73
262
1690
304
1865
3.17
26.53
8.6
4.3
10.70
12.63
umol/l
2.80
296
1772
347
2307
3.66
26.26
9.0
5.1
6.82
6.85
mmol/l
0.11
339
2205
132
551
3.02
22.78
7.0
2.6
20.63
23.92
%
2.53
124
514
154
703
2.86
22.52
3.7
2.1
2.48
2.44
mmol/l
2.69
132
615
145
648
2.87
21.98
6.5
2.6
10.94
13.15
umol/l
4.18
137
599
138
601
2.91
21.95
6.8
2.5
2.16
2.22
g/l
0.51
128
556
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
54
131
4.57
20.98
2.1
2.6
0.31
0.39
iu/ml
0.68
19
69
80
259
3.57
20.88
8.5
3.4
23.75
24.56
mmol/l
1.77
80
254
30
42
7.61
20.61
3.5
2.4
—
596.00
—
0
7
199
1086
2.56
19.83
4.7
2.6
391.76
368.69
umol/l
2.43
182
934
87
311
3.26
19.32
3.7
1.6
66.01
67.19
g/l
0.65
82
289
130
611
2.62
17.29
4.2
2.7
0.80
0.83
mmol/l
2.27
124
575
46
118
4.25
16.57
3.1
1.3
1.50
1.35
ratio
0.25
28
68
108
476
2.70
16.23
8.3
3.2
5.74
5.81
kpa
0.34
108
458
26
41
6.69
16.01
1.2
1.2
—
—
—
0
0
84
333
2.89
15.38
2.8
2.3
41.95
50.29
u/l
0.25
77
265
105
472
2.62
15.07
8.4
3.2
0.76
2.17
mmol/l
3.82
95
402
56
189
3.26
13.48
2.3
1.8
1.87
1.55
g/l
1.21
48
170
272
1910
2.16
12.98
4.9
3.5
0.00
0.00
estimate
-0.00
64
361
276
1958
2.15
12.71
5.1
3.6
0.00
0.02
estimate
0.93
62
335
190
1180
2.10
12.38
3.2
2.5
165.72
62.53
u/l
0.67
177
1096
163
957
2.14
12.30
2.5
2.3
3.02
2.73
mg/l
0.79
144
816
271
1937
2.09
11.87
5.1
3.6
0.00
0.00
estimate
-0.00
64
368
69
284
2.70
11.62
4.3
2.2
39.53
63.17
ml/min/173m2
7.06
43
118
24
50
5.03
11.09
2.9
1.5
170.00
155.44
au/ml
0.25
12
16
33
92
3.80
10.58
1.9
1.4
—
—
—
0
0
227
1567
1.96
10.44
5.4
3.6
6.95
8.25
mmol/l
6.83
197
1334
81
385
2.36
10.02
2.8
2.3
8.77
7.40
umol/l
0.29
71
346
83
399
2.34
10.01
6.0
2.8
5.05
4.62
kpa
0.91
83
381
342
2748
2.22
10.00
6.0
4.3
16.69
11.72
mm/h
4.11
320
2552
33
97
3.60
9.80
1.9
1.4
—
—
—
0
0
224
1564
1.91
9.72
6.4
4.4
22.18
7.44
mg/mmol
3.52
169
1039
121
686
2.06
9.64
2.4
1.9
—
—
—
0
0
220
1533
1.90
9.54
5.9
2.9
187.53
154.19
ug/l
0.78
212
1419
22
49
4.68
9.41
1.4
1.4
—
—
—
0
0
404
3538
3.53
9.25
33.1
15.2
37.46
26.09
mg/l
6.28
377
2879
12
5
24.62
8.95
13.0
10.2
5.46
4.60
mmol/l
—
12
5
24
61
4.11
8.72
1.7
1.1
319.50
271.14
u/ml
0.27
16
29
32
103
3.28
8.28
3.4
3.2
0.74
1.78
index
1.12
19
64
13
9
14.85
8.25
3.3
2.7
0.57
0.58
mmol/l
—
13
9
218
1565
1.80
8.16
3.6
2.4
79.13
77.29
nmol/l
0.43
195
1384
26
77
3.53
7.65
1.3
1.4
—
—
—
0
0
26
77
3.53
7.65
1.3
1.4
—
—
—
0
0
132
836
1.84
7.31
4.6
4.2
72.68
467.81
ng/l
3.34
120
702
54
246
2.37
7.28
5.7
4.0
0.55
2.06
mmol/l
1.96
43
186
56
265
2.28
6.92
2.3
1.6
—
—
—
0
0
52
239
2.34
6.87
1.6
1.5
—
—
—
0
0
89
506
1.96
6.82
2.4
1.8
—
—
—
0
0
295
2387
1.76
6.68
3.9
3.4
55.49
51.80
u/l
0.35
273
2235
74
399
2.03
6.57
4.9
2.9
—
—
—
0
0
170
1196
1.70
6.38
4.4
2.9
29.84
34.73
u/l
0.92
164
1118
92
542
1.89
6.31
2.3
1.8
—
—
—
0
0
17
43
4.08
6.22
3.5
1.7
1695.65
1162.53
mg
0.40
17
43
10
8
12.76
6.11
1.0
1.0
—
—
—
0
0
36
153
2.48
5.65
2.2
1.6
0.63
2.34
ug/l
1.31
29
136
60
324
1.99
5.28
6.1
2.8
119.13
132.44
g/l
4.09
60
315
169
1235
1.61
5.23
1.9
1.7
19.49
19.73
nmol/l
0.07
155
1027
23
81
2.94
5.17
1.5
1.7
—
—
—
0
0
25
94
2.76
5.00
1.4
1.4
—
—
—
0
0
407
3762
2.67
4.92
45.6
19.5
139.14
139.81
mmol/l
6.22
400
3692
407
3770
2.62
4.75
46.5
19.5
4.11
4.02
mmol/l
6.33
400
3695
60
339
1.90
4.63
2.8
1.7
417.18
374.90
nmol/l
0.98
55
315
183
1394
1.55
4.58
3.1
3.2
3168.57
1372.55
ng/l
1.85
157
1198
24
93
2.67
4.55
1.4
1.4
—
—
—
0
0
15
44
3.50
4.50
2.4
1.7
28.39
39.88
u/ml
0.20
15
38
25
101
2.57
4.38
4.7
2.4
122.20
133.02
g/l
0.89
20
81
28
120
2.43
4.35
1.4
1.3
—
—
—
0
0
232
1875
1.52
4.33
2.3
2.2
100.89
94.62
pmol/l
0.91
132
990
115
797
1.61
4.30
1.6
1.6
1.17
1.41
mg/l
0.63
92
616
382
3481
1.91
4.21
36.9
14.7
62.90
77.19
ml/min/173m2
23.09
370
3238
40
211
1.99
3.78
1.6
1.4
—
—
—
0
0
33
163
2.11
3.71
7.1
4.4
24.03
24.96
mmol/l
0.83
27
149
22
92
2.47
3.62
1.7
1.5
—
—
—
0
0
19
74
2.64
3.60
1.3
1.3
—
—
—
0
0
16
57
2.88
3.56
1.3
1.5
—
—
—
0
0
8
13
6.25
3.51
1.1
1.3
—
—
—
0
0
22
94
2.41
3.47
1.4
1.7
—
—
—
0
0
21
88
2.46
3.45
1.4
1.3
—
—
—
0
0
31
158
2.04
3.23
1.7
1.9
32.84
39.06
u/l
0.84
31
140
12
34
3.60
3.22
1.1
1.5
—
—
—
0
0
20
87
2.36
3.05
1.1
1.3
—
—
—
0
0
12
36
3.40
3.04
1.1
1.5
—
—
—
0
0
263
2270
1.41
2.98
6.1
4.3
2.19
1.90
ug/l
1.24
249
2046
16
64
2.56
2.90
1.3
1.3
—
—
—
0
0
166
1330
1.41
2.88
3.7
2.9
0.82
0.72
ug/l
1.03
130
885
31
166
1.94
2.84
2.5
3.2
—
—
—
0
0
21
97
2.23
2.82
1.6
1.3
—
—
—
0
0
12
39
3.14
2.79
4.9
2.3
—
—
—
0
0
128
989
1.42
2.70
4.5
3.2
0.00
0.00
estimate
0.50
53
283
402
3810
1.91
2.67
19.4
10.8
25.25
27.44
u/l
2.55
392
3678
220
1880
1.35
2.45
3.1
2.5
—
—
—
0
0
20
97
2.11
2.41
1.4
3.5
25.87
35.25
umol/l
1.75
15
88
17
77
2.26
2.40
1.5
1.3
—
—
—
0
0
7
17
4.17
2.37
1.1
2.1
946.86
1320.12
u/ml
—
7
17
20
100
2.05
2.24
1.5
1.4
321.75
295.72
ug/g
0.24
12
63
16
73
2.24
2.24
1.6
1.9
721.63
265.42
mu/l
0.42
16
67
11
41
2.73
2.22
1.3
1.5
—
—
—
0
0
407
3899
1.89
2.20
53.1
22.8
4.36
4.57
e12/l
11.21
398
3795
407
3899
1.89
2.20
53.3
22.8
249.86
235.25
e9/l
4.14
400
3814
8
24
3.38
2.19
1.0
1.2
120.63
96.71
pmol/l
—
8
24
6
14
4.33
2.16
1.3
1.1
—
—
—
0
0
6
14
4.33
2.16
1.3
1.1
—
—
—
0
0
6
14
4.33
2.16
1.3
1.1
—
—
—
0
0
6
14
4.33
2.16
1.3
1.1
—
—
—
0
0
172
1437
1.33
2.15
5.3
3.6
0.00
0.01
estimate
0.80
56
298
5
10
5.04
2.07
1.2
1.1
—
—
—
0
0
5
10
5.04
2.07
1.2
1.2
—
—
—
0
0
5
10
5.04
2.07
1.2
1.1
—
—
—
0
0
25
140
1.83
2.05
2.4
1.7
—
—
—
0
0
6
15
4.04
2.04
1.0
1.3
—
—
—
0
0
8
26
3.12
2.02
1.0
1.0
—
—
—
0
0
8
26
3.12
2.02
1.0
1.0
—
—
—
0
0
9
32
2.85
2.01
1.2
1.2
—
—
—
0
0
9
32
2.85
2.01
1.2
1.2
—
—
—
0
0
9
32
2.85
2.01
1.2
1.2
—
—
—
0
0
7
21
3.37
1.97
2.1
1.6
177.30
87.61
ng/l
—
7
21
10
39
2.60
1.95
1.5
1.2
—
—
—
0
0
6
16
3.79
1.94
1.3
1.8
—
—
—
0
0
6
16
3.79
1.94
1.3
1.8
—
—
—
0
0
23
130
1.81
1.85
2.1
1.6
—
—
—
0
0
29
176
1.69
1.85
1.9
1.9
—
—
—
0
0
16
81
2.01
1.77
1.3
1.3
—
455.56
—
0
9
188
1625
1.28
1.74
4.6
4.1
48.84
89.95
ng/l
0.70
154
1261
5
13
3.88
1.72
3.2
2.2
4.22
4.08
nmol/l
—
5
13
11
48
2.33
1.72
1.1
1.4
—
—
—
0
0
130
1076
1.30
1.68
5.7
3.6
0.00
0.01
estimate
0.69
56
331
159
1351
1.28
1.67
2.3
2.2
128.57
287.88
u/l
2.19
152
1268
6
19
3.19
1.66
1.0
1.1
—
—
—
0
0
57
415
1.43
1.66
1.2
1.4
—
—
—
0
0
20
113
1.81
1.63
2.1
1.4
0.24
0.23
g/l
0.11
20
108
21
122
1.76
1.57
1.4
1.5
10712.23
13363.88
e6/l
0.20
13
90
46
325
1.47
1.57
1.4
1.5
—
—
—
0
0
88
696
1.33
1.56
1.9
1.8
1343.00
1137.87
nmol/l
0.49
69
531
290
2664
1.27
1.55
4.5
3.6
15.02
14.96
pmol/l
0.15
265
2406
20
115
1.78
1.55
2.0
1.4
1.25
1.17
g/l
0.52
20
108
11
51
2.19
1.52
3.3
3.9
—
—
—
0
0
17
94
1.84
1.49
1.4
1.6
—
—
—
0
0
36
247
1.50
1.43
7.5
3.6
49.29
49.59
%
0.02
36
238
15
81
1.88
1.42
1.0
1.2
—
1.13
—
0
6
351
3319
1.32
1.41
5.5
4.7
1.95
2.01
mu/l
0.37
324
3020
23
145
1.62
1.32
1.2
1.2
86.50
135.41
u/ml
—
6
59
8
34
2.38
1.30
1.0
1.1
—
—
—
0
0
29
196
1.51
1.25
2.1
1.9
—
—
—
0
0
6
25
2.42
1.24
3.7
2.7
1.00
1.08
index
—
6
25
20
124
1.64
1.23
4.5
2.4
88.73
81.11
ug/min
0.07
15
70
206
1852
1.22
1.22
4.9
3.9
23.55
23.64
%
0.03
115
863
21
135
1.58
1.13
1.1
1.0
—
—
—
0
0
15
89
1.71
1.09
1.0
1.2
—
—
—
0
0
7
33
2.14
1.06
1.0
1.3
—
—
—
0
0
7
33
2.14
1.06
1.0
1.3
—
—
—
0
0
7
33
2.14
1.06
1.0
1.3
—
—
—
0
0
7
35
2.02
1.00
1.0
1.3
—
—
—
0
0
7
35
2.02
1.00
1.0
1.3
—
—
—
0
0
7
35
2.02
1.00
1.0
1.3
—
—
—
0
0
84
702
1.24
0.99
1.3
1.3
1.61
1.39
u/ml
0.13
18
189
15
92
1.65
0.98
1.0
1.3
—
2.61
—
0
13
371
3575
1.28
0.98
8.9
7.4
40.25
40.38
mmol/mol
0.10
346
3350
15
93
1.64
0.95
1.0
1.3
—
3.64
—
0
19
373
3600
1.28
0.94
6.3
5.6
6.19
6.11
mmol/l
0.44
335
3293
6
27
2.24
0.94
1.3
1.2
—
—
—
0
0
384
3722
1.31
0.92
6.9
6.6
2.36
2.56
mmol/l
4.60
353
3464
6
28
2.16
0.92
1.7
1.5
—
—
—
0
0
61
497
1.27
0.90
5.4
5.4
31.45
31.83
%
0.10
42
330
8
42
1.92
0.89
1.0
1.1
—
—
—
0
0
8
43
1.88
0.87
1.1
1.1
—
—
—
0
0
31
230
1.37
0.87
7.1
2.8
23.97
25.24
mmol/l
1.61
31
219
6
30
2.01
0.87
1.2
1.4
—
—
—
0
0
8
47
1.72
0.81
1.3
1.1
—
—
—
0
0
0
26
0.00
0.78
0.0
2.9
—
—
—
0
0
5
99
0.50
0.78
2.0
1.2
1.10
0.92
g/l
—
5
99
24
180
1.35
0.66
1.4
1.7
0.28
0.40
mg/l
0.77
14
88
5
29
1.73
0.64
1.0
1.2
—
—
—
0
0
358
3475
1.18
0.62
5.1
4.8
1.48
1.32
mmol/l
3.19
314
3200
5
30
1.67
0.61
1.0
1.2
—
—
—
0
0
16
220
0.72
0.60
2.0
1.9
4.25
3.51
mmol/l
—
10
172
374
3649
1.20
0.58
6.1
5.7
4.26
4.39
mmol/l
1.72
347
3412
6
35
1.72
0.58
1.5
1.6
—
—
—
0
0
6
36
1.68
0.57
1.0
1.2
—
94.60
—
0
5
6
37
1.63
0.55
1.0
1.2
—
—
—
0
0
9
60
1.51
0.54
1.0
1.1
1.61
1.58
g/l
—
9
55
6
38
1.59
0.54
3.8
2.7
17.33
11.32
index
—
6
25
5
31
1.62
0.43
1.0
1.2
—
—
—
0
0
5
31
1.62
0.43
1.0
1.2
—
—
—
0
0
54
475
1.16
0.41
2.3
2.5
12.48
15.60
nmol/l
2.82
46
431
5
33
1.52
0.41
4.4
1.2
—
—
—
0
0
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
0
17
0.00
0.40
0.0
1.4
—
12.29
—
0
17
5
35
1.43
0.39
1.0
1.2
—
—
—
0
0
25
298
0.83
0.36
2.4
2.2
4.23
3.65
ratio
1.07
18
245
6
87
0.69
0.33
1.0
1.3
—
—
—
0
0
306
2983
1.09
0.33
47.9
19.9
329.94
333.68
g/l
9.96
306
2971
13
102
1.28
0.30
1.2
1.5
—
—
—
0
0
368
3625
1.11
0.28
6.1
5.6
1.30
1.37
mmol/l
2.46
339
3363
23
197
1.18
0.26
1.6
2.0
39.30
42.15
nmol/l
0.25
23
186
51
557
0.90
0.25
1.3
1.3
22.51
6.96
u/ml
0.48
14
197
6
85
0.70
0.24
1.0
1.1
—
2.19
—
0
12
0
11
0.00
0.21
0.0
10.2
—
10.40
—
0
11
6
50
1.20
0.20
3.5
2.3
11.50
10.71
mmol/l
—
6
50
56
599
0.93
0.18
1.3
1.3
99.26
32.18
iu/ml
0.66
14
164
16
179
0.89
0.12
1.8
1.4
—
—
—
0
0
86
889
0.96
0.10
5.9
3.8
1.02
1.02
kg/l
0.04
69
592
5
48
1.04
0.09
1.6
1.3
1.30
1.63
nmol/l
—
5
41
52
498
1.05
0.09
12.3
7.0
—
—
—
0
0
6
55
1.09
0.09
2.2
2.7
—
—
—
0
0
45
430
1.05
0.08
1.9
2.0
1.98
1.62
%
0.96
40
361
10
89
1.13
0.07
1.3
1.1
—
—
—
0
0
10
89
1.13
0.07
1.3
1.1
—
—
—
0
0
14
128
1.10
0.07
1.3
1.2
—
—
—
0
0
170
1678
1.02
0.06
2.2
2.0
1.51
1.33
mmol/l
1.65
150
1384
45
441
1.02
0.02
2.6
2.6
5.56
8.20
ug/l
1.15
39
393
86
850
1.01
0.02
2.0
1.8
462.56
22428987.48
pmol/l
0.69
73
700
12
124
0.97
0.00
4.4
3.1
1.10
1.57
mmol/l
2.79
12
119
11
109
1.01
0.00
4.4
3.1
6.85
7.19
mmol/l
0.22
11
104
0
7
0.00
-0.00
0.0
1.0
—
33.29
—
0
7
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
5
49
1.02
-0.00
2.4
2.8
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
0.15
—
0
7
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
5
56
0.89
-0.00
3.4
2.6
1.23
1.18
mmol/l
—
5
56
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
54
0.93
-0.00
1.2
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
1.56
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.3
—
—
—
0
0
5
59
0.85
-0.00
3.4
2.5
109.00
105.41
mmol/l
—
5
59
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_KIDNEY_PAPILLARYADENO – Adenocarcinoma and Papillary adenocarcinoma of kidney
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).